Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant

Yuan Wang1, Jiong Yang, Huarui Zheng

  • 1Department of Internal Medicine, Division of Molecular Medicine and Genetics, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

Cancer Cell
|May 30, 2009
PubMed

Insights

p53 deficiency alone doesn't drive brain cell growth but enables cooperative oncogenic alterations. Mutant p53 accumulation in neural stem cells initiates glioma formation in the subventricular zone.

Area of Science:

  • Neuro-oncology
  • Cancer genetics
  • Glioblastoma research

Background:

  • Glioblastoma involves altered genes and pathways, but transformation mechanisms and cell of origin are unclear.
  • Understanding these mechanisms is crucial for developing effective glioblastoma treatments.

Purpose of the Study:

  • To investigate the role of p53 mutations in glioblastoma initiation.
  • To identify the cell of origin for glioblastoma development.
  • To elucidate the cooperative mechanisms driving gliomagenesis.

Main Methods:

  • Targeting an in-frame p53 deletion mutation to the brain in a model system.
  • Analyzing p53 protein accumulation in neural stem cells and progenitor cells.
  • Identifying specific cell populations involved in glioma formation.

Main Results:

  • p53 deficiency alone did not significantly enhance adult brain cell growth.
  • Mutant p53 accumulation was first detected in subventricular zone (SVZ) neural stem cells.
  • Glioma formation was initiated by the expansion of mutant p53-expressing Olig2(+) progenitor-like cells in SVZ-associated areas.

Conclusions:

  • p53 deficiency acts as a critical early event, facilitating the accumulation of cooperative oncogenic alterations.
  • Neural stem cells in the SVZ are a likely cell of origin for glioblastoma.
  • Olig2(+) progenitor-like cells play a key role in initiating glioma formation upon p53 mutation.